BioPharm. Smart Outsourcing: Strategic Alignment, Risk Management, and New Relationships

Similar documents
Smart Outsourcing: Strategic Alignment, Risk Management, and New Relationships

Sponsor/CRO Partnership Optimization

Redefining Time to Market

Let s talk: governance

The velocity of change

Guidance Note: Corporate Governance - Board of Directors. January Ce document est aussi disponible en français.

Make money, save money and manage risk

Five Guiding Principles of a Successful Center of Excellence

ENHANCING CLINICAL DATA QUALITY WITH SPECIALIZED FUNCTIONAL SERVICE PROVIDER MODEL

GxP Auditing, Remediation, and Quality System Resourcing

Adopt New SAP Innovations Early And Win

POSITION DESCRIPTION. Senior Director of Innovation and Commercialization Location:

GxP Auditing, Remediation, and Staff Augmentation

Introduction. "We commend its wide adoption." 2

Transaction Advisory Services. Operational Transaction Services. Working with you to make your transaction a success

A New Approach to Outsourced Drug Development:

GxP Auditing, Remediation, and Staff Augmentation

Advisory & Client Services

Robert Posgai Director of Materials Procurement, Biogen (BPOG)

See the world. differently. Embrace change and profit from marketplace uncertainty

How it works: Questions from the OCAT 2.0

ICMI PROFESSIONAL CERTIFICATION

Executive Vice President, Member Networks Washington, D.C.

IT Governance Overview

QUICK FACTS. Supporting a Healthcare Provider s Transformation to ICD-10 TEKSYSTEMS GLOBAL SERVICES CUSTOMER SUCCESS STORIES.

THREE -YEAR STRATEGIC PLAN

ScienceDirect. Survey Framework for Understanding Value of Service

Tim Moore Global Head, Pharmaceutical Technical Operations Biologics, Genentech a member of the Roche Group

Strategic Partnership

Managed Services for High-Growth Biopharmaceutical Companies. Centralize, optimize and scale your contingent workforce program

Re: Special Notice on Potential Enhancements to Certain Engagement Programs

Policy Administration Transformation

Example Approach To Non-Profit Organizations. ExeComp Solutions Compensation Advisory Services May 2014

Vendor Support Agreements: A Competitive Weapon for Optimizing Organizational Assets

Modernizing compliance: Moving from value protection to value creation

HOW TO LAUNCH A SUCCESSFUL WORKFORCE PLANNING CENTER OF EXPERTISE (COE)

Risk Management in the 21 st Century Ameren Business Risk Management

1 THE FUTURE OF WORK

whitepaper managing fluctuating demand through a scalable FSP model. randstad life sciences

INTERNATIONAL ACCOUNTING EDUCATION STANDARDS BOARD STRATEGY AND WORK PLAN March 2017

How can regulatory affairs drive greater value for the patient and for the business?

Let s embrace tomorrow, Today. Empowering solutions for your business

EARLY PHASE DEVELOPMENT SOLUTIONS

An integrated model approach to improve the management of marketed products

Getting Started with BPM. Kathleen Donahue, Sr. Director, BPM Deb Boykin, Director, BPM June 22, 2010

Passion for Excellence. Commitment to Delivery.

2013 Southwind Institute

Understanding and Mitigating IT Project Risks BY MIKE BAILEY AND MIKE RIFFEL

Performance Management in Higher Education

Information Services Group Public Sector

THREE-YEAR STRATEGIC PLAN UPDATE v1

About Accenture s values

Portfolio, Programme and Project Management (P3M3) Maturity Questionnaire

Management Update: The CRM Service Provider Magic Quadrant for the Americas

Significant Service Contracts Framework

PROJECT MANAGEMENT OVERVIEW

Preparing your organization for a Human Resource Outsourcing implementation

Job Family Matrix. Core Duties Core Duties Core Duties

adp.ca Outsourcing: Today s Approach to Doing More with Less Your guide to getting the most from your HR outsourcing experience

Make money, save money and manage risk. The benefits of well-designed environment, health, safety and sustainability programs

Manager Service Performance & Integration

Stepping Into the Future of Pharmacovigilance

JOB TITLE: Senior Planning and Portfolio Manager Planning Funding and Population Health

Chapter One PROJECT MANAGEMENT OVERVIEW

PORTLAND PUBLIC SCHOOLS HUMAN RESOURCE SERVICES AND DELIVERY

3PL Selection Strategies

QUICK FACTS. Delivering Business Intelligence to a Large Software Company TEKSYSTEMS GLOBAL SERVICES CUSTOMER SUCCESS STORIES.

MSP Purpose, Value & ROI

POSITION NUMBER: LOCATION: Vancouver. DATE: January 2013

Creating a Risk Intelligent Enterprise: Risk governance

The Current State of Risk Management Maturity for Belgian Organizations kpmg.com/be

Leveraging BPM to Realize Supply Chain Value. Deb Boykin, Director, BPM May 4, 2011

Business Process Services: A Value-Based Approach to Process Improvement and Delivery

Guidance Note: Corporate Governance - Audit Committee. March Ce document est aussi disponible en français.

Mergers and Acquisitions in the Biotechnology Industry

Achieving High Performance in Industrial Equipment. Engineering a Global Advantage

Guidance Note: Corporate Governance - Audit Committee. January Ce document est aussi disponible en français.

Ref: Federal Participation in the Development and Use of Voluntary Consensus Standards and in Conformity Assessment Activities.

BEST PRACTICE GUIDE Getting Started with Kronos Workforce Analytics for Healthcare

The Communications Audit NEVER MORE RELEVANT, NEVER MORE VALUABLE:

Introduction. The Assessment consists of:

Manitoba Health, Seniors and Active Living Transformation Program Charter. February 16, 2018 Version 1.0

QAIassist Integrated Methodology Project Management Lifecycle Implementation Guide

QAIassist Integrated Methodology Software Testing Lifecycle Implementation Guide

IT MANAGER - BUSINESS & TECHNOLOGY APPLICATIONS (12235) ( )

Building a Change Capable Organization: Breaking Ground (PART 2 OF 2) LAMARSH.COM

EY Center for Board Matters. Leading practices for audit committees

Enterprise Risk Management Framework

IT GOVERNANCE AND MANAGED SERVICES Creating a win-win relationship

To 3PL or Not to 3PL:

AUDITING. Auditing PAGE 1

PAREXEL PARTNER PROGRAM. Broaden your reach with a partner you can trust

COMPLIANCE TRUMPS RISK

Job description and person specification

Operational Service and Operational Enterprise Agencies Core Competencies

Columbus Water Works. Five Year Strategic Plan FY

QAIassist Integrated Methodology Software Development Lifecycle (SDLC) Implementation Guide

The Ohio State University Human Resources Strategic Plan

QUICK FACTS. Driving Improved Incident Management and Resolution for a Law Firm TEKSYSTEMS GLOBAL SERVICES CUSTOMER SUCCESS STORIES

Transcription:

BioPharm Volume 25 Number 3 INTERNATIONAL March 2012 The Science & Business of Biopharmaceuticals Smart Outsourcing: Strategic Alignment, Risk Management, and New Relationships Outsourcing decisions should be made to foster potential long-term strategic partnerships. William Schmidt and Ian Uydess Outsourcing in the pharmaceutical industry, until recently, has been largely confined to commercial manufacturing, packaging, and support for clinical trials. The industry is rapidly changing; companies are facing rising costs, a fast evolving global market, and weak pipelines. Many companies are outsourcing activities that have historically been kept in house, freeing themselves to concentrate on their core competencies and become more agile in responding to changing conditions. These new outsourcing models include discovery and R&D, regulatory, chemistry and manufacturing controls (CMC) support, and back office sales and marketing activities virtually no activity is out of bounds. Instead of building or acquiring specialized technologies and facilities, many companies are seeking access to them elsewhere. Smart outsourcing provides the following operational and business benefits: Reduced operating costs and greater return on investment (ROI) Shorter time to market through faster accesses to increased capacity, new technologies, specialized facilities, intellectual property (IP), and expertise More efficient use of critical internal resources (e.g., human and facilities) Avoidance of large expenditures to bring new or expanded capabilities in house as well as the cost of staffing those capabilities Increased velocity and flexibility in responding to rapidly changing global markets. To reap the full rewards of outsourcing over the long term and significantly enhance shareholder value, however, companies need to take a comprehensive approach. Companies that adopt a smart outsourcing strategy include: Pursuing outsourcing in the context of an end-toend, global supply chain strategy that is directly aligned with the company s strategic business goals Managing outsourcing as part of a continuing, mutually beneficial, long-term strategic partnership Assessing and effectively managing the increased risk that comes with more extensive and diverse outsourcing. Companies can use outside expertise to help carry out such an approach. This article outlines the benefits of using a third party in strategic outsourcing. Leveraging external expertise Effective use of outside experts who have the requisite industry-specific technical, quality and compliance, operational, and business experience can provide an invaluable, independent source of perspective, meth- William Schmidt is a vice-president at Tunnell Consulting, Inc. and Ian Uydess, PhD, is a managing consultant and project manager at Tunnell Consulting, Inc. william.schmidt@tunnellconsulting.com, ian.uydess@ tunnellconsulting.com.

Due Diligence Checklist Capacity: Does the partner have the capabilities and capacity needed but also the flexibility to grow so there will be no disruption to the supply chain as needs and markets grow? Is the partner willing to make contractual obligations to deliver on this? What is the partner s past history with other partners and customers? Technical capability: Does the partner have the technologies and technical capabilities to support business goals in the near term, as well as the commitment, resources, and flexibility to introduce new technologies as the pipeline and products evolve in the future? Is their workforce experienced and flexible enough to support this? Quality and compliance systems: Does the partner have reliable and proven quality and compliance systems in place, and how much visibility would the company have into those systems? Will the partner inform the company of any issues that may come up, and work proactively to help resolve them so they won t be repeated again (i.e., corrective actions and preventive actions [CAPA])? Compliance history: What is the partner s track record with US and other regulatory agencies, and what is the likelihood of compliance problems in the future? Quality culture: Above and beyond written processes and procedures, does the partner show commitment to maintaining a reliable state of quality and compliance in all company activities, and at all levels, so that the likelihood of interruptions of supply due to poor quality or compliance performance will be low and the dedication to excellence high? Roles, responsibilities, and governance: Have the respective roles, responsibilities, and accountabilities of the sponsor and outsource provider been discussed and agreed upon, and are they clearly understood? Has a formal communications, notification, and decision-making process been put in place? Have the appropriate senior leadership, project management, and other key resources been identified on each side of the relationship to determine who will have responsibility for communicating and making decisions about potential issues that may come up? IP management: To what degree might the partnership put intellectual property at risk, especially if the company moves up the value chain in the kind of activity that is being outsourced? Single versus multisource: Is single or multisourcing the best strategy for cost and risk management as well as to help assure continuity of the supply chain? Organizational cultural compatibility: To what extent do the two parties share similar visions, values, and behaviors to support an effective and mutually rewarding partnership and the drive for continuous improvement? Are there any major disconnects or warning signs of potential trouble? Regulatory: What are the routine regulatory risks of the partnership as well as the unique risks posed by the nature of the partnership or outsourced activity? odologies, and tools to help ensure the best decisions are made each step of the way. Experts can help to tightly align outsourcing strategies with a company s strategic business and supply chain plans, re-affirm core competencies, and make informed recommendations regarding which current outsourcing needs represent the highest ROIs and competitive advantages going forward. The right consulting partner can give advice on how best to support these strategies with ongoing operational excellence and risk-management programs, as well as develop and maintain highly effective and mutually beneficial strategic relationships with prospective outsource providers. But whether a company engages external advisors or not, the company will need to be able to skillfully blend strategy, risk management, and a new mindset and approach to outsourcing partnerships to remain competitive in today s, and tomorrow s, rapidly changing and increasingly challenging global markets. A new kind of partnership The effective selection, qualification, and management of outsource partners begins with s2 Supplement to BioPharm International March 2012 www.biopharminternational.com

the way one thinks about those partners, no matter what the nature of the partnership (e.g., innovator CMO or innovator-toinnovator). Short-term thinking about outsourcing as a stopgap measure or commodity solution to operational needs based largely on cost or capacity must be replaced by thoughtful and robust evaluations of both the current and future benefits of developing long-range strategic partnerships that deliver flexibility and value to both parties involved. Consider not only what outsource partners can provide in the near term, but also what they may be able to do as the relationship grows. Long-term strategic partnerships can have substantial benefits to each of the outsource partners in revenue, capacity planning, and potential access to new technologies and markets. For example, consider that two large pharmaceutical companies enter into mutually beneficial, long-term (>10 years) strategic relationships. These are innovator-to-innovator partnerships that are based on a progressive schedule of mutual exploration and cooperation. Among their short- and longterm goals are the use of each other s available capacity and specialized facilities, technical and scientific information-sharing, and potentially, the codevelopment of future products and technologies. Maintaining such long-term, strategic partnerships requires a significant shift in thinking and organizational culture on both sides from a purely transactional relationship to one of shared planning, shared risk, and collaboration. This shift requires developing and nurturing a highly cooperative working relationship that incorporates trust, a shared vision, open communication, and a dedication to quality, timeliness, compliance, and continuous improvement. Risk-based due diligence Selecting a strategic outsourcing partner goes far beyond a checklist of their capacity, capabilities, and cost. A company should thoroughly assess all of the risks associated with that partnership, develop the appropriate remediation plans and contingencies with the potential partner, and agree to jointly manage those risks to successful outcomes. Conducting a thorough and intelligent riskbased due diligence, performed as a shared exercise with the outsource partner, can identify key areas of uncertainty that need to be addressed. Due diligence can also help align each party s expectations with regard to their relative roles and responsibilities, accountability, and what success looks like for each of the parties involved. A number of alternative riskassessment and risk-management methodologies and toolboxes exist. One should be selected that effectively identifies, prioritizes, and helps manage the risks that exist but that also provides an objective and quantifiable output that clearly supports the business case for that outsourcing decision. Key areas to be considered in these risk-based assessments are outlined in the sidebar (see Due Diligence Checklist ). At the conclusion of the assessment, both the company and potential outsource partner should have a comprehensive profile of the major risks of the overall outsourcing strategy, including those related to time, cost, and deliverables as well as the degree of regulatory, operational, and cultural risk. The prospective partners can then collaboratively determine the relative priorities of those risks to each party, how those risks will be mitigated, and the contingency plans that will need to be put in place. The time and cost of mitigating each risk and the ROI for doing this must also be carefully considered so that an informed business decision can be made about entering into the relationship. This risk-based assessment should not be a single undertaking. Conditions change and risks change with them. The evaluation should, therefore, be conducted periodically as a formal part of the business relationship process in order to continue to manage change and uncertainty, assure alignment of the partners with the goals and deliverables of the agreement, and to validate that the work or services being conducted continues to support the strategic supply chain and business strategy. Establishing and maintaining successful relationships The success of strategic outsourcing relationships, both in the short and long term, depends upon effective planning and project management, appropriate metrics, successful knowledge transfer, ongoing open communication, and periodic reassessment to help assure the long-term viability and health of these critical business partnerships. Effective planning begins with the development and exe- www.biopharminternational.com March 2012 Supplement to BioPharm International s3

cution of the appropriate business and quality agreements that clearly define and specify the relative roles, relationships, specifications, and deliverables that are expected. These include the proper controls and contingencies that may be needed to address any unexpected situations that may arise. Metrics must be established to serve as an early warning system for potential issues and to measure the relative success of the outcomes that are expected. It is also highly recommended that companies establish dedicated resources to manage these relationships as they move to a broader and more strategic sourcing strategy. These dedicated resources should also monitor progress against plans, quality of the deliverables, costs, and other parameters that have been set forth in the business, technical, and quality agreements. The relationship begins in earnest with complete and reliable IP and knowledge transfer between the sponsor and the contract partner, including effective technical transfer if the outsourcing involves a process to be run or product to be made. Companies that intend to engage in outsourcing need to assure they have an effective information and technology transfer process in place that is formal, efficient, scientifically and technically sound, compliant, cost-effective, and reliable. This is a core competency that consistently produces maximum strategic impact. Too often, however, such transfers are treated as one-off events that are the responsibility of a single function, department, or site, rather than part of a comprehensive transfer framework supported by well-trained and experienced resources on both sides of the agreement. That framework should include the following: An overall transfer program management process, including a governance structure, the establishment of executive sponsorship, and the clear delineation of roles and responsibilities, including those of support functions and transfers. In this way, the company can manage its outsourcing transfers as a portfolio and apply risk management techniques to the portfolio as a whole. Project-level management for each individual transfer, including a set of requirements, activities, decision points, milestones and best practices that help ensure predictable, on-time transfer that is able to be validated. Transfer strategy, including the means to fill any gaps in the organization or the receiving organization, an overall description of the transfer, and measures of success. Process understanding and control When a process or product is being transferred, the organization must have the proper level of process understanding and control over that product or process so that it can provide clear, complete, and technically sound specifications to ensure successful transfer. Elements for achieving process understanding include employing QbD principles and techniques; identifying the appropriate critical-to-quality attributes and associated critical process parameters to limit variability and maximize control; identifying drivers of variation and of interactions in critical processes; and understanding the right process-control strategies. When older or insufficiently developed processes with a high or uncertain level of variability must be transferred, improved control can usually be obtained retrospectively from conducting a highly structured, statistical analysis of the historic data associated with those processes. Such process capability and control evaluations, if implemented properly, can help achieve an improved level of understanding and control over these older and more variable processes in a relatively short period of time, often in just weeks. The risk of prolonged and costly transfer attempts, or even failure, is thereby, significantly reduced. Achieving process robustness is a critical success factor for rightfirst-time transfers to outsource partners, as well as successful validation and reliable operation of those transfers. Sustaining the relationship Once the operational relationship is under way, the open and honest two-way communications, continued risk assessment, and cooperative problem solving upon which the partnership was first based must continue. This can t be emphasized strongly enough. Too often when outsource providers encounter technical problems or have quality or compliance issues, they tend to conceal those problems from the client while they attempt to resolve the issues on their own. Sooner or later, news of the problem comes to the attention of the client as a sudden and unexpected surprise, with potential negative impact on both the cli- s4 Supplement to BioPharm International March 2012 www.biopharminternational.com

ent and outsource partner. What otherwise may have been a minor problem potentially escalates into a major issue, which could have been more effectively managed if the outsource partner had communicated with the client and enlisted their help in a more timely and effective manner. Conversely, clients must keep the outsource provider fully informed of plans that will increase or reduce the volume and level of services that will be required so they can plan their resources and capacity accordingly. Finally, continue to assess the strategic outsourcing strategy at regular intervals to assure continued alignment with the strategic business goals of the company, the strategic supply chain strategy, as well as with changing patient needs and market conditions. Conduct a regular re-assessment of the performance history and potential risk at each of the partners along with a re-assessment of the entire outsourcing portfolio. This will help assure the continued success of those partnerships, the identification and remediation of any new risks that may arise, and also help to identify additional opportunities for strategic outsourcing as your company continues to evolve and grow. Questions to be asked during re-assessments include: What are the highest-priority and highest-roi opportunities for additional outsourcing that will support manufacture of our current products, introduction of future products, and overall strategic business plan? Are there some outsourced projects that should be brought back in house? Has there been a shift in any of our core competencies, technologies, or internal capacity to support our current and upcoming products? Has there been a shift in our company s strategic business or supply chain plans as a result of changing competition, patient, or market conditions? What are the relative priorities, timing, costs, risks, competitive advantages, and ROI of making a change in our current outsourcing strategy? What if the change isn t made? The bottom line is that today s outsourcing decisions should be thought of as potential long-term strategic partnerships in support of an overall strategic supply chain strategy, and aligned closely with the business goals of the company. Decisions should be based on a solid business case, technical, and quality foundation that is further supported by a robust risk-based assessment and management methodology. Only then can the most important requirement of all on both sides of the relationship be fulfilled, thereby protecting and enhancing shareholder value. BP Posted with permission from the March 2012 supplement of BioPharm International. Copyright 2012, an Advanstar publication. All rights reserved. www.biopharminternational.com #C6998 Managed by The YGS Group, 800.290.5460. For more information visit www.theygsgroup.com/content. Founded in 1962 and serving many of the world s leading life sciences firms, Tunnell Consulting integrates strategic, technical, process, and organizational skills to design and implement sustainable solutions that exactly meet client needs. With deep industry knowledge, extensive scientific credentials, and superior measurable results, we consistently boost the operating performance of each unique client we serve. tunnellconsulting.com Headquarters 900 East Eighth Avenue, Suite 106 King of Prussia, PA 19406 610.337.0820 King of Prussia, PA Washington, DC